AMN Healthcare Services, Inc.

NYSE•AMN

CEO: Ms. Caroline Sullivan Grace

セクター: Healthcare

業種: Medical - Care Facilities

上場日: 2001-11-13

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

連絡先情報

8840 Cypress Waters Boulevard, Suite 300, Dallas, TX, 75019, United States

866-871-8519

www.amnhealthcare.com

時価総額

$787.89M

PER (TTM)

-8.3

16.4

配当利回り

52週高値

$27.17

52週安値

$14.87

52週レンジ

45%

順位24Top 10.8%

5.7

F-Score

改良版 Piotroski 分析

10年ファンダメンタル

堅調 • 5.7 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$748.23M+0.00%

直近4四半期の推移

EPS

-$0.20+0.00%

直近4四半期の推移

フリーCF

$67.63M+0.00%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Net Loss Significantly Narrows Net loss reduced to $(95.7)M in 2025 from $(147.0)M loss in 2024, showing margin recovery efforts.

Labor Disruption Revenue Boost Nurse and allied segment revenue gained $127.9M from labor disruption support during Q4 2025 events.

Major Debt Redemption Completed Successfully redeemed $500.0M aggregate principal amount of 2027 Senior Notes during the fourth quarter of 2025.

Operating Cash Flow Remains Strong Cash provided by operating activities totaled $269.5M for 2025, supporting liquidity needs and capital structure.

リスク要因

Overall Revenue Declined Consolidated revenue fell 8% to $2.73B in 2025, driven by declines across all reportable segments.

Significant Impairment Charges Recognized $109.5M goodwill impairment and $18.3M long-lived asset impairment during the fiscal year 2025.

Gross Margin Compression Gross margin decreased to 28.3% in 2025 from 30.8% in 2024 due to pay package costs and sales mix.

High Client Concentration Risk Kaiser Foundation Hospitals represented 22% of 2025 consolidated revenue, posing material adverse effect risk if lost.

見通し

Investing in Technology & AI Increasing investments in automation and AI-enabled technology to realize greater scale, agility, speed, and cost efficiencies.

Expanding Talent Solutions Strategy focuses on market penetration, expanding talent solutions, and increasing qualified healthcare professional supply through 2026.

Human Capital Management Focus Strategy prioritizes talent acquisition, engagement, retention, and well-being for corporate team members and professionals.

同業比較

売上高 (TTM)

AMN

$2.73B

-8.5%

EVH

$1.88B

-26.6%

PNTG

$947.71M

+36.3%

粗利益率 (最新四半期)

VIR

672.1%

-54902.1pp

IOVA

215.9%

+65.9pp

DNA

124.4%

-21.7pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
IOVA	$1.61B	-5.0	-54.5%	5.3%
VIR	$1.37B	-3.1	-49.3%	18.6%
PNTG	$1.18B	39.9	9.3%	46.8%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

2.8%

緩やかな成長

4四半期純利益CAGR

N/M

収益構造の変化

キャッシュフロー安定性

100%

優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年4月30日

EPS:$1.62

売上高:$1.23B

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし